ArticleBMC pediatrics2026
Echocardiographic assessment of cardiac involvement in pediatric COVID-19 patients: a cross-sectional study.
Article in BMC pediatrics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundCardiac involvement has emerged as a significant complication in children with COVID-19, particularly in those with multisystem inflammatory syndrome in children (MIS-C). However, systematic echocardiographic data remain limited, especially from the Middle East.
methodsIn this descriptive cross-sectional study, 433 children with confirmed COVID-19 admitted to a tertiary hospital in Tehran were evaluated. Transthoracic echocardiography was performed in all patients during hospitalization. Cardiac function, valvular regurgitation, pericardial and pleural effusion, and coronary artery dimensions (Z-score-based) were recorded. Findings were compared between MIS-C and non-MIS-C patients.
resultsAmong 433 patients (mean age 4.56 years; 54% male), 270 (62.5%) were diagnosed with MIS-C. The most common echocardiographic abnormalities were mitral regurgitation (19.4%) and pericardial effusion (18.5%). Coronary abnormalities (1.4%) and LV systolic dysfunction (4.8%) were uncommon. MIS-C patients had significantly higher rates of pericardial effusion (23% vs. 11%, p = 0.002). Pericardial effusion was the only variable significantly associated with ICU admission (p = 0.002). Pleural effusion was observed only in non-MIS-C patients (3.1%, p = 0.003).
conclusionsEchocardiographic abnormalities are common in children hospitalized with COVID-19, particularly those with MIS-C. Pericardial effusion may serve as an early marker of severity and guide triage. Routine cardiac imaging is recommended in hospitalized children with inflammatory symptoms.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.